Overview
With the management of one GMP site and the undergoing mega-project of a new manufacturing unit at the Industrial Zone of Keratea, Pharmazac has entered dynamically into the field of production and quality control. In 2019 the estimated functional manufacturing area will be 12.920 sq.m., covering a wide spectrum of pharmaceutical and food supplemtns forms.
CMO Strategy
We offer contract manufacturing solutions and options to selected clients for pharmaceutical products, food supplements and dermocosmetics. Pharmazac’s strategy is to work closely with prospective clients to invest in their needs and work on various levels of batch sizes.